FMC Schedules Q4 2025 Earnings Release and Conference Call Details
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: PRnewswire
- Earnings Release Schedule: FMC Corporation will release its Q4 2025 earnings on February 4, 2026, after market close, reflecting its ongoing performance and adaptability in the agricultural sciences sector.
- Conference Call Timing: The company will host a webcast conference call on February 5, 2026, at 9:00 a.m. ET, providing a detailed interpretation of its financial performance to enhance investor transparency.
- Global Dial-In Information: FMC offers multiple dial-in options for global investors, demonstrating its commitment to international investor relations and support.
- Replay Arrangement: The conference call replay will be available from 11:00 a.m. ET on February 5 until February 12, allowing investors who cannot attend live to access the information, thereby improving information accessibility.
FMC
$13.18+Infinity%1D
Analyst Views on FMC
Wall Street analysts forecast FMC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FMC is 20.25 USD with a low forecast of 14.00 USD and a high forecast of 39.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
2 Buy
11 Hold
0 Sell
Hold
Current: 13.320
Low
14.00
Averages
20.25
High
39.00
Current: 13.320
Low
14.00
Averages
20.25
High
39.00
About FMC
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
